As of 2025-11-18, the Relative Valuation of AbL Diagnostics SA (ABLD.PA) is 0.75 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 2.90 EUR, the upside of AbL Diagnostics SA based on Relative Valuation is -74.1%.
The range of the Relative Valuation is 0.41 - 1.09 EUR.
| Range | Selected | |
| Trailing P/E multiples | 34.1x - 38.0x | 36.0x |
| Forward P/E multiples | 14.3x - 17.9x | 16.1x |
| Fair Price | 0.41 - 1.09 | 0.75 |
| Upside | -85.8% - -62.3% | -74.1% |
| Date | P/E |
| 2025-11-17 | 100.82 |
| 2025-11-14 | 103.61 |
| 2025-11-13 | 97.35 |
| 2025-11-12 | 135.59 |
| 2025-11-11 | 118.21 |
| 2025-11-10 | 95.96 |
| 2025-11-07 | 102.22 |
| 2025-11-06 | 108.47 |
| 2025-11-05 | 120.99 |
| 2025-11-04 | 130.72 |
| 2025-11-03 | 140.46 |
| 2025-10-31 | 155.76 |
| 2025-10-30 | 155.76 |
| 2025-10-29 | 156.45 |
| 2025-10-28 | 155.76 |
| 2025-10-27 | 155.76 |
| 2025-10-24 | 156.45 |
| 2025-10-23 | 156.45 |
| 2025-10-22 | 156.45 |
| 2025-10-21 | 157.84 |
| 2025-10-20 | 155.76 |
| 2025-10-17 | 157.15 |
| 2025-10-16 | 157.15 |
| 2025-10-15 | 157.84 |
| 2025-10-14 | 157.15 |
| 2025-10-13 | 157.84 |
| 2025-10-10 | 156.45 |
| 2025-10-09 | 156.45 |
| 2025-10-08 | 155.76 |
| 2025-10-07 | 155.76 |
| 2025-10-06 | 155.76 |
| 2025-10-03 | 155.76 |
| 2025-10-02 | 155.76 |
| 2025-10-01 | 156.45 |
| 2025-09-30 | 156.45 |
| 2025-09-29 | 156.45 |
| 2025-09-26 | 156.45 |
| 2025-09-25 | 156.45 |
| 2025-09-24 | 156.45 |
| 2025-09-23 | 156.45 |
| 2025-09-22 | 152.97 |
| 2025-09-19 | 152.97 |
| 2025-09-18 | 155.76 |
| 2025-09-17 | 156.45 |
| 2025-09-16 | 170.36 |
| 2025-09-15 | 170.36 |
| 2025-09-12 | 170.36 |
| 2025-09-11 | 166.88 |
| 2025-09-10 | 166.88 |
| 2025-09-09 | 166.88 |